Additive interaction between the renin-angiotensin system and lipid metabolism for cancer in type 2 diabetes

Diabetes

Volumn 58, Issue 7, 2009, Pages 1518-1525

  Yang, Xilin ^a   Zhao, Hailu ^a   Sui, Yi ^a   Ma, Ronald C W ^a   Wing, Yee So ^a   Ko, Gary T C ^a   Kong, Alice P S ^a   Ozaki, Risa ^a   Chun, Yip Yeung ^a   Xu, Gang ^a   Tong, Peter C Y ^a   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LISINOPRIL; ORAL ANTIDIABETIC AGENT; SOMATOMEDIN C;

ADULT; AGED; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CHINESE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG POTENTIATION; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SIGNAL TRANSDUCTION; UNINEPHRECTOMY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARCINOMA, RENAL CELL; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; HONG KONG; HUMANS; INPATIENTS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY FUNCTION TESTS; KIDNEY NEOPLASMS; LIPIDS; LISINOPRIL; NEOPLASMS; OUTPATIENTS; RATS; RATS, SPRAGUE-DAWLEY; REGISTRIES; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 67650260797     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db09-0105     Document Type: Article

References (47)

1. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202
2. Seow A, Yuan JM, Koh WP, Lee HP, Yu MC. Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst 2006;98:135-138
3. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92:2076-2083
4. Rousseau MC, Parent ME, Pollak MN, Siemiatycki J. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 2006;118:2105-2109
5. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE. Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 2006;98:349-356
6. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007;50:1365-1374
7. Rodriguez C, Patel AV, Mondul AM, Jacobs EJ, Thun MJ, Calle EE. Diabetes and risk of prostate cancer in a prospective cohort of US men. Am J Epidemiol 2005;161:147-152
8. Yang X, So WY, Ko GT, Ma RC, Kong AP, Chow CC, Tong PC, Chan JC. Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus. CMAJ 2008;179:427-437
9. Yang X, So WY, Ma RC, Ko GT, Kong AP, Wang Q, Cockram CS, Chow CC, Chan JC, Tong PC. Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes. Endocr Relat Cancer 2008;15:597-607
10. Attoub S, Gaben AM, Al-Salam S, Al Sultan MA, John A, Nicholls MG, Mester J, Petroianu G. Captopril as a potential inhibitor of lung tumor growth and metastasis. Ann NY Acad Sci 2008;1138:65-72
11. Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. J Natl Cancer Inst 2008;100:1223-1232
12. Ager EI, Neo J, Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008;29:1675-1684
13. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-1278
14. Bonovas S, Sitaras NM. Does pravastatin promote cancer in elderly patients? A meta-analysis. CMAJ 2007;176:649-654
15. Gurley SB, Coffman TM. The renin-angiotensin system and diabetic nephropathy. Semin Nephrol 2007;27:144-152
16. Ramos-Nino ME, Maclean CD, Littenberg B. Association of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont Diabetes Information System. BMC Endocr Disord 2008;8:17
17. Singh BM, Mehta JL. Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med 2003;163:1296-1304
18. Chen J, Li D, Schaefer R, Mehta JL. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis 2006;184:295-301
19. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8:915-928
20. Carlberg M, Dricu A, Blegen H, Wang M, Hjertman M, Zickert P, Hoog A, Larsson O. Mevalonic acid is limiting for N-linked glycosylation and translocation of the insulin-like growth factor-1 receptor to the cell surface: evidence for a new link between 3-hydroxy-3-methylglutarylcoenzyme a reductase and cell growth. J Biol Chem 1996;271:17453-17462
21. Girnita L, Wang M, Xie Y, Nilsson G, Dricu A, Wejde J, Larsson O. Inhibition of N-linked glycosylation down-regulates insulin-like growth factor-1 receptor at the cell surface and kills Ewing's sarcoma cells: therapeutic implications. Anticancer Drug Des 2000;15:67-72
22. Sekine Y, Furuya Y, Nishii M, Koike H, Matsui H, Suzuki K. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via downregulation of the insulin-like growth factor 1 receptor. Biochem Biophys Res Commun 2008;372:356-361
23. van Eickels M, Vetter H, Grohe C. Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation. Br J Pharmacol 2000;131:1592-1596
24. Onder G, Liperoti R, Russo A, Capoluongo E, Minucci A, Lulli P, Cesari M, Maggio M, Bernabei R, Landi F. Use of ACE inhibitors is associated with elevated levels of IGFBP-3 among hypertensive older adults: results from the IlSIRENTE study. Eur J Clin Pharmacol 2007;63:389-395
25. Grollman A, Halpert B. Renal lesions in chronic hypertension induced by unilateral nephrectomy in the rat. Proc Soc Exp Biol Med 1949;71:394-398
26. Fotino S. The solitary kidney: a model of chronic hyperfiltration in humans. Am J Kidney Dis 1989;13:88-98
27. Sui Y, Zhao HL, Ma RC, Ho CS, Kong AP, Lai FM, Ng HK, Rowlands DK, Chan JC, Tong PC. Pancreatic islet β-cell deficit and glucose intolerance in rats with uninephrectomy. Cell Mol Life Sci 2007;64:3119-3128
28. Zhao HL, Sui Y, Guan J, He L, Zhu X, Fan RR, Xu G, Kong AP, Ho CS, Lai FM, Rowlands DK, Chan JC, Tong PC. Fat redistribution and adipocyte transformation in uninephrectomized rats. Kidney Int 2008;74:467-477
29. Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M, Diabetes Care Monitoring Group of the St. Vincent Declaration Steering Committee. Monitoring the targets of the St. Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. Diabet Med 1993;10:371-377
30. World Health Organization Regional Office for the Western Pacific. Hong Kong (China): health system [Internet], 2005. Available from www.wpro. who.int/countries/hkg/national-health-priorities.htm. Accessed on 15 July 2008
31. Laakso M, Pyorala K. Age of onset and type of diabetes. Diabetes Care 1985;8:114-117
32. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
33. Ahlbom A, Alfredsson L. Interaction: a word with two meanings creates confusion. Eur J Epidemiol 2005;20:563-564
34. Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol 2005;20:575-579
35. Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol 2007;17:227-236
36. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol 1999;150:327-333
37. Poynter JN, Gruber SB, Higgins PD, Almog R, Bonner JD, Rennert HS, Low M, Greenson JK, Rennert G. Statins and the risk of colorectal cancer. N Engl J Med 2005;352:2184-2192
38. Browning DR, Martin RM. Statins and risk of cancer: a systematic review and metaanalysis. Int J Cancer 2007;120:833-843
39. Iwata H, Aoyama T, Kusumi E, Hamaki T, Kami M. Limitations of a meta-analysis investigating the association between cancer and statin use. Am J Med 2002;112:157-158
40. Coleman CI, Baker WL, Kluger J, White CM. Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens 2008;26:622-629
41. van der Knaap R, Siemes C, Coebergh JW, van Duijn CM, Hofman A, Stricker BH. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer 2008;112:748-757
42. Uemura H, Ishiguro H, Ishiguro Y, Hoshino K, Takahashi S, Kubota Y. Angiotensin II induces oxidative stress in prostate cancer. Mol Cancer Res 2008;6:250-258
43. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-1353
44. Leri A, Liu Y, Claudio PP, Kajstura J, Wang X, Wang S, Kang P, Malhotra A, Anversa P. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. Am J Pathol 1999;154:567-580
45. Bhasker CR, Friedmann T. Insulin-like growth factor-1 coordinately induces the expression of fatty acid and cholesterol biosynthetic genes in murine C2C12 myoblasts. BMC Genomics 2008;9:535
46. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006;166:1871-1877
47. Yang X, So WY, Tong PC, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V, Chan JC. Development and validation of an all-cause mortality risk score in type 2 diabetes - The Hong Kong Diabetes Registry. Arch Intern Med 2008;168:451-457